Having memory problems or trouble thinking clearly?

If this sounds like you, or someone you know, please consider the EMERGE Study.

Having memory problems or trouble thinking clearly? If this sounds like you, or someone you know, please consider the EMERGE Study.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Alzheimer's Disease Clinical Trial
NCT02484547 | Phase 3 | Interventional
What you may receive

Compensation of $100 per visit for xx visits

Biogen
Sponsored by
Biogen

Having memory problems or trouble thinking clearly?

If this sounds like you, or someone you know, please consider the EMERGE Study.

Having memory problems or trouble thinking clearly? If this sounds like you, or someone you know, please consider the EMERGE Study.

Active not recruiting

Male & Female

50 - 85

years old

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the effect of monthly doses of aducanumab as compared with placebo on clinical progression as measured by Mini-Mental State Examination (MMSE), AD Assessment Scale-Cognitive Subscale (13 items) [ADAS-Cog 13], and AD Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment version) [ADCS-ADL-MCI].

Why should I participate?

The EMERGE Study is a global study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease.

There is an important medical and scientific need to research therapies that could delay memory loss and the progression of disability in Alzheimer’s disease because there are currently no approved treatments that slow the course of the condition.

What's involved?

You will need a study partner – someone who is close to you, such as a family member or close friend – to attend certain study visits with you and provide information on your health and well-being.If eligible, all study medication, examinations, and medical care related to the study will be provided at no cost to you. Reasonable compensation for time and travel may be provided.

Who can participate?

You may be able to take part in the EMERGE Study if you are 50 –85 years of age and are experiencing symptoms that might be related to early Alzheimer’s disease, such as problems with memory or thinking clearly.

Available locations
Clinical Trial Network

Clinical Trial Network

Recruiting 7080 Southwest Freeway, Houston, TX, USA 77074

Research Site

Research Site

Recruiting Shizuoka-shi, Shizuoka-Ken, JPN 420-8688

Meridien Research

Meridien Research

Active not recruiting Brooksville, FL, USA 34601

Lehigh Center for Clinical Research LLC

Lehigh Center for Clinical Research LLC

Active not recruiting 401 North 17th Street, Allentown, PA, USA 18104

Klinikum Altenburger Land GmbH

Klinikum Altenburger Land GmbH

Active not recruiting Altenburg, Thueringen, DEU 04600

Alzheimer Research Center

Alzheimer Research Center

Active not recruiting 2 Cronenburg, Amsterdam, NLD 1081 GM

Emory University Cognitive Neurology Clinic ADRC

Emory University Cognitive Neurology Clinic ADRC

Active not recruiting Atlanta, GA, USA 30329

JEM Research Institute

JEM Research Institute

Active not recruiting Atlantis, FL, USA 33462

University of Colorado Denver

University of Colorado Denver

Active not recruiting 13001 East 17th Place, Aurora, CO, USA 80045

Interested in participating?
Biogen
Sponsored by Biogen

To get started, please choose a location